[PLX] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 15.94%
YoY- -4.89%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 4,670 5,846 3,707 3,359 5,390 1,132 3,184 6.58%
PBT -7,290 -3,820 -8,010 -5,747 -5,479 0 0 -
Tax 268 17 49 0 -81 108 -374 -
NP -7,290 -3,820 -8,010 -5,747 -5,479 -8,875 -2,474 19.71%
Tax Rate - - - - - - - -
Total Cost 11,960 9,666 11,717 9,106 10,869 10,007 5,658 13.27%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin -156.10 -65.34 -216.08 -171.09 -101.65 -784.01 -77.70 12.31%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS -0.07 -0.04 -0.09 -0.06 -0.06 -0.10 -0.03 15.15%
EPS Diluted -0.07 -0.04 -0.09 -0.06 -0.06 -0.10 -0.03 15.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.